Bliss GVS Pharma Grants 295,000 ESOPs at Rs. 43 per Share
Bliss GVS Pharma Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 10:52 pm
Bliss GVS Pharma Grants 295,000 ESOPs at Rs. 43 per Share Bliss GVS Pharma鈥檚 Nomination and Remuneration Committee granted 2,95,000 stock options under its ESOP Plan 2019 on 29th Oct'26, convertible into an equivalent number of equity shares with a face value of Re. 1 each. The options carry an exercise price of Rs. 43 per share, based on BSE's closing price on 28th Oct'26. Vesting is scheduled equally at 25% annually over four years, exercisable within six months of vesting. Shares allotted post-exercise will face a six-month lock-in period.
Original exchange filing (PDF)
More announcements from Bliss GVS Pharma Ltd
- Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations. 路 06 Nov 2026
- We wish to inform you that Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma Limited, has obtained marketing authorization from the Medicines & Healthcare products .... 路 04 Nov 2026
- Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. 路 29 Oct 2026
- Bliss GVS Pharma Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 29 Oct 2026
